Blood-brain barrier permeability of gefitinib in patients with brain metastases from non-small-cell lung cancer before and during whole brain radiation therapy

Oncotarget
Yin-Duo ZengLi-Kun Chen

Abstract

To explore the ability of gefitinib to penetrate blood brain barrier (BBB) during whole brain radiation therapy (WBRT). Enrolled in this study were eligible patients who were diagnosed with BM from NSCLC. Gefitinib was given at 250 mg/day for 30 days, then concurrently with WBRT (40 Gy/20 F/4 w), followed by maintenance. Serial CSF and blood samples were collected on 30 day after gefitinib administration, and at the time of 10, 20, 30 and 40 Gy following WBRT. CSF and plasma samples of 13 patients without BM who were treated with gefitinib were collected as control. CSF and plasma gefitinib levels were measured by LC-MS/MS. Fifteen BM patients completed gefitinib plus WBRT. The CSF-to-plasma ratio of gefitinib in patients with BM was higher than that in patients without BM (1.34% vs. 0.36%, P < 0.001). The CSF-to-plasma ratio of gefitinib increased with the increased dose of WBRT and reached the peak (1.87 ± 0.72%) at 30 Gy, which was significantly higher than that 1.34 ± 0.49% at 0 Gy (P = 0.01). The median time to progression of brain lesions and the median overall survival were 7.07 and 15.4 months, respectively. The BBB permeability of gefitinib increased in accordance with escalated dose of WBRT.

References

Dec 1, 1990·International Journal of Radiation Oncology, Biology, Physics·D X QinY H Hu
Jun 1, 1997·American Journal of Clinical Oncology·D QinZ Tang
Mar 22, 2002·The Lancet Oncology·Isaiah J FidlerCorazon D Bucana
May 29, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Hidenori TakahashiHidetada Sasaki
Jun 19, 2004·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G L CeresoliE Villa
Oct 12, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Katsuyuki HottaMitsune Tanimoto
Dec 18, 2004·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Chao-Hua ChiuReury-Perng Perng
Jul 15, 2005·The New England Journal of Medicine·Frances A ShepherdUNKNOWN National Cancer Institute of Canada Clinical Trials Group
Nov 10, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Andrew B LassmanEric C Holland
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·David M JackmanBruce E Johnson
Mar 3, 2007·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Alberto BroniscerClinton F Stewart
Apr 17, 2007·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Chi WuZhong Wei
Jan 4, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Chien-Hung GowPan-Chyr Yang
Dec 19, 2008·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Shenglin MaXinmin Yu
Jun 2, 2009·International Journal of Radiation Oncology, Biology, Physics·Christy M WilsonThomas E Merchant
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
May 19, 2010·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Yosuke TogashiMichiaki Mishima
Dec 17, 2010·Cancer Chemotherapy and Pharmacology·Amit KhatriMark N Kirstein
Nov 19, 2011·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Gianfranco A PesceRoger Stupp
Dec 14, 2011·Current Oncology Reports·Sean A Grimm
Jul 19, 2012·Cancer Chemotherapy and Pharmacology·Yosuke TogashiMichiaki Mishima
Aug 1, 2012·Clinical Lung Cancer·Jing ZhaoMengzhao Wang
Jan 24, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·James W WelshBaldassarre Stea

❮ Previous
Next ❯

Citations

Feb 19, 2016·Future Oncology·Rimas V LukasRavi Salgia
Apr 10, 2017·Current Treatment Options in Oncology·Tresa McGranahan, Seema Nagpal
Jul 31, 2018·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Yi-Long WuTony S K Mok
Aug 25, 2018·Frontiers in Oncology·Ana TurkajSilvia Novello
Jan 18, 2019·Chinese Neurosurgical Journal·Qi LiuJiangfei Wang
Oct 7, 2015·Expert Opinion on Pharmacotherapy·Giulio MetroLucio Crinò
Oct 12, 2019·Nature Reviews. Cancer·Costas D ArvanitisRakesh K Jain
Jul 15, 2018·Nature Communications·Brunilde GrilPatricia S Steeg
Jan 27, 2019·Cancer Research·Hila DoronNeta Erez
Feb 3, 2021·International Journal of Molecular Sciences·Justine ParisGuilhem Bousquet
Apr 25, 2021·Brain : a Journal of Neurology·Jawad FaresMaciej S Lesniak
Oct 19, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A V TalletY M Kirova
Jan 3, 2018·Annals of Oncology : Official Journal of the European Society for Medical Oncology·G GossJ C-H Yang
Sep 22, 2021·Journal of Biomedical Nanotechnology·Mengyao WangZhiyong Qian

❮ Previous
Next ❯

Software Mentioned

SPSS

Related Concepts

Related Feeds

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Blood Brain Barrier Regulation in Health & Disease

The blood brain barrier is essential in regulating the movement of molecules and substances in and out of the brain. Disruption to the blood brain barrier and changes in permeability allow pathogens and inflammatory molecules to cross the barrier and may play a part in the pathogenesis of neurodegenerative disorders. Here is the latest research in this field.

CSF & Lymphatic System

This feed focuses on Cerebral Spinal Fluid (CSF) and the lymphatic system. Discover the latest papers using imaging techniques to track CSF outflow into the lymphatic system in animal models.

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.